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Background: Leishmania (L.) are intracellular protozoan para-
sites able to survive and replicate in the hostile phagolysosomal
environment of infected macrophages. They cause leishmaniasis,
a heterogeneous group of worldwide-distributed affections, repre-
senting aparadigmofneglecteddiseases that aremainly embedded
in impoverished populations. To establish successful infection and
ensure their own survival, Leishmania have developed sophisti-
cated strategies to subvert the hostmacrophage responses. Despite
a wealth of gained crucial information, these strategies still remain
poorly understood. MicroRNAs (miRNAs), an evolutionarily con-
served class of endogenous 22-nucleotide non-coding RNAs, are
described to participate in the regulation of almost every cellular
process investigated so far. They regulate the expression of tar-
get genes both at the levels of mRNA stability and translation;
changes in their expression have a profound effect on their target
transcripts.
Methods & Materials: We report in this study a comprehensive
analysis of miRNA expression proﬁles in L. major-infectedhuman
primary macrophages of three healthy donors assessed at different
time- points post-infection (3h, 6h, 12h and 24h)
Results: We show that expression of 64, out of 365 analyzed
miRNAs, were consistently deregulated upon infection with the
same trends in all donors. GO enrichment analysis of experi-
mentally validated miRNA-targeted genes revealed that several
pathways and molecular functions were disturbed upon parasite
infection.
Among the experimentally validated targeted transcripts of
up-regulated miRNAs at 3h, 6h and 12h, several belong to the
chemokine family. Negative correlation between expression lev-
els of a selected up-regulated set of miRNAs (let-7a, miR-25,
miR-26a, miR-140 or miR-155 among others) and of mRNA of
their corresponding chemokine targets (i.e., CCL2, CCL5, CXCL10,
CXCL11 and CXCL12). Finally, following parasite infection, miR-
210 abundance was enhanced in hypoxia-induced factor-1 alpha
(HIF-1a)-dependent manner.
Conclusion: Our data suggest that alteration in miRNA levels
likely play important role in regulating macrophage functions fol-
lowing L. major infection. These results could contribute to better
understanding the dynamics of gene expression in host cells during
leishmaniasis.
The two ﬁrst authors contributed equally to this work and the
two last authors co-directed this study.
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Fulminant amebic colitis in an
immunocompetent patient: A case report
B.R. Martins, J.C.G. Duarte ∗, F.F. Fonseca
Instituto de Infectologia Emilio Ribas, Sao Paulo,
Brazil
Background: Amebiasis is caused by the protozoa Entamoeba
histolytica and can present as an intestinal or extraintesti-
nal disease.Amebic colitis is more common in developing
countries.Entamoeba histolytica infectious is generally asymp-
tomatic, but 0,5% of amebiasis cases presents as a fulminant colitis,
with a high mortality rate.
Methods & Materials: We report a case of colonic amebiasis
in which the clinical presentation resembled severe inﬂammatory
bowel disease.
Results: A previously healthy 47-year-old-man, was admitted
to our Hospital with a bloody diarrhea, fecal incontinence, fever
and mild abdominal pain of 3 months of duration, associated a lost
weightof 40kg.Hehasalreadybeen tootherhospitals, and received
treatment for intestinal parasitosis. It was ﬁrst considered sepsis
from abdominal origin, and introduced Cefepime and Metronida-
zole,without satisfactory clinical improvement. Theexaminationof
stool for protozoawaspositive for Entamoebahistolytica/dispar, he
was re-treated with all current available treatment, but there was
no relief of symptoms.He needed blood transfusion after several
intestinal bleeding episodes and sulfasalazine and corticoid was
introduced in attempt of treating and inﬂammatory bowel disease
as colonoscopydemonstrated severe ulcerative colitis. Pathological
examinationof rectal biopsy showedproctitis ulceration associated
with E. histolytica.His symptoms worsened with more relevant
bleeding, he became malnourishedand needed intensive unit care.
During his stayed at the hospital developed Clostridium difﬁcile
pseudomembranous colitis, with toxin test positive, also treated.
After 3 months hospitalized, with stool test negatives for both
amoeba and clostridium, without clinical improvement, he was
ﬁnally submitted to exploratory laparotomy and it was seen the
all the colon was compromised with intense inﬂammatory reac-
tion. A total colectomy with terminal ileostomy was performed
withprogressive improvement, andhewasdischarged to ileostomy
resconstruction surgery later.
Conclusion: The purpose of this presentation is to
emphasize that speciﬁc antimoebic therapy associated with
colonic ressection is the treatment of choice and decreasemortality
of amebic colitis.
http://dx.doi.org/10.1016/j.ijid.2014.03.773
